An observational study in Financial Toxicity Related to Cancer Diagnosis and Tretment in Adolescents and Young Adults, sponsored by University Medical Center Goettingen. Enrolling by invitation at 1 site in Germany. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-01-02.
Sponsored by University Medical Center Goettingen · Observational
The FINCARE-Young study aims to investigate the extent and development of financial toxicity in adolescents and young adults with cancer. The primary purpose of this study is to assess the level of financial burden experienced during the acute phase of cancer treatment and after completion of therapy, and to analyze changes over time. In addition, the study seeks to identify sociodemographic, clinical, and socioeconomic factors associated with financial toxicity, as well as its impact on employment and social reintegration. By focusing on young adult cancer survivors, this study addresses an underexplored population and seeks to generate evidence to improve supportive care strategies and reduce long-term financial consequences of cancer.
University Medical Center Goettingen is the lead sponsor of 61 studies on the registry; 27 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population will be selected from adolescents and young adults with a history of cancer who were treated at the University Medical Center Göttingen, a tertiary care academic hospital in Germany. Potential participants are identified through institutional clinical databases and electronic medical records. The source population includes individuals who received oncological care across all cancer entities within this center over the defined study period and who can be contacted for follow-up after completion of therapy.
Exclusion Criteria:
This cohort consists of adolescents and young adults aged 18 to 39 years at the time of initial cancer diagnosis who received oncological treatment at a single tertiary care center. Participants have completed their primary cancer therapy and are assessed retrospectively and prospectively. The study does not involve any therapeutic intervention. Data are collected through structured telephone interviews and standardized questionnaires, complemented by clinical data extracted from electronic medical records. The focus of the cohort is to evaluate financial toxicity, socioeconomic factors, and employment-related outcomes following cancer treatment.
Financial toxicity
Financial toxicity, assessed using the Comprehensive Score for Financial Toxicity (COST) questionnaire, measured during the acute phase of cancer treatment and at the time of study participation, including change over time.
Time frame: From the acute phase of cancer treatment to the time of study participation after completion of therapy (retrospective assessment of treatment period and current assessment at follow-up), assessed only at one time point at study enrollment.
Plan to share: No — Individual participant data will not be shared because the study involves highly sensitive personal, medical, and socioeconomic information. Sharing individual-level data could pose a risk to participant privacy and confidentiality, even after pseudonymization, and is therefore not planned.
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Medical Center Goettingen